These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 31892008)
1. A comprehensive analysis of liposomal biomolecular corona upon human plasma incubation: The evolution towards the lipid corona. La Barbera G; Capriotti AL; Caracciolo G; Cavaliere C; Cerrato A; Montone CM; Piovesana S; Pozzi D; Quagliarini E; Laganà A Talanta; 2020 Mar; 209():120487. PubMed ID: 31892008 [TBL] [Abstract][Full Text] [Related]
2. Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/DNA nanoparticles. Caracciolo G; Cardarelli F; Pozzi D; Salomone F; Maccari G; Bardi G; Capriotti AL; Cavaliere C; Papi M; Laganà A ACS Appl Mater Interfaces; 2013 Dec; 5(24):13171-9. PubMed ID: 24245615 [TBL] [Abstract][Full Text] [Related]
3. Tuning liposome composition to modulate corona formation in human serum and cellular uptake. Yang K; Mesquita B; Horvatovich P; Salvati A Acta Biomater; 2020 Apr; 106():314-327. PubMed ID: 32081780 [TBL] [Abstract][Full Text] [Related]
4. The lipidomic profile of the nanoparticle-biomolecule corona reflects the diversity of plasma lipids. Papafilippou L; Nicolaou A; Kendall AC; Camacho-Muñoz D; Hadjidemetriou M Nanoscale; 2023 Jul; 15(26):11038-11051. PubMed ID: 37357917 [TBL] [Abstract][Full Text] [Related]
5. The liposome-protein corona in mice and humans and its implications for in vivo delivery. Caracciolo G; Pozzi D; Capriotti AL; Cavaliere C; Piovesana S; La Barbera G; Amici A; Laganà A J Mater Chem B; 2014 Nov; 2(42):7419-7428. PubMed ID: 32261967 [TBL] [Abstract][Full Text] [Related]
6. What the cell surface does not see: The gene vector under the protein corona. Motta S; Rondelli V; Cantu L; Del Favero E; Aureli M; Pozzi D; Caracciolo G; Brocca P Colloids Surf B Biointerfaces; 2016 May; 141():170-178. PubMed ID: 26852100 [TBL] [Abstract][Full Text] [Related]
7. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles. Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229 [TBL] [Abstract][Full Text] [Related]
8. The Impact of Lipid Types and Liposomal Formulations on Osteoblast Adiposity and Mineralization. Chang SF; Yeh CC; Chen PJ; Chang HI Molecules; 2018 Jan; 23(1):. PubMed ID: 29301300 [TBL] [Abstract][Full Text] [Related]
9. Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. Pozzi D; Colapicchioni V; Caracciolo G; Piovesana S; Capriotti AL; Palchetti S; De Grossi S; Riccioli A; Amenitsch H; Laganà A Nanoscale; 2014 Mar; 6(5):2782-92. PubMed ID: 24463404 [TBL] [Abstract][Full Text] [Related]
11. Variations in metabolite profiles of serum coronas produced around PEGylated liposomal drugs by surface property. Jang GJ; Jeong JY; Joung H; Han SY Colloids Surf B Biointerfaces; 2023 Oct; 230():113488. PubMed ID: 37574616 [TBL] [Abstract][Full Text] [Related]
12. Human Biomolecular Corona of Liposomal Doxorubicin: The Overlooked Factor in Anticancer Drug Delivery. Caracciolo G; Palchetti S; Digiacomo L; Chiozzi RZZ; Capriotti AL; Amenitsch H; Tentori PM; Palmieri V; Papi M; Cardarelli F; Pozzi D; Laganà A ACS Appl Mater Interfaces; 2018 Jul; 10(27):22951-22962. PubMed ID: 29905462 [TBL] [Abstract][Full Text] [Related]
13. The protein corona of circulating PEGylated liposomes. Palchetti S; Colapicchioni V; Digiacomo L; Caracciolo G; Pozzi D; Capriotti AL; La Barbera G; Laganà A Biochim Biophys Acta; 2016 Feb; 1858(2):189-96. PubMed ID: 26607013 [TBL] [Abstract][Full Text] [Related]
14. Liposome protein corona characterization as a new approach in nanomedicine. Capriotti AL; Cavaliere C; Piovesana S Anal Bioanal Chem; 2019 Jul; 411(19):4313-4326. PubMed ID: 30758528 [TBL] [Abstract][Full Text] [Related]
15. Optimization of metabolite extraction of human vein tissue for ultra performance liquid chromatography-mass spectrometry and nuclear magnetic resonance-based untargeted metabolic profiling. Anwar MA; Vorkas PA; Li JV; Shalhoub J; Want EJ; Davies AH; Holmes E Analyst; 2015 Nov; 140(22):7586-97. PubMed ID: 26468486 [TBL] [Abstract][Full Text] [Related]
16. Evolution of the protein corona of lipid gene vectors as a function of plasma concentration. Caracciolo G; Pozzi D; Capriotti AL; Cavaliere C; Foglia P; Amenitsch H; Laganà A Langmuir; 2011 Dec; 27(24):15048-53. PubMed ID: 22043822 [TBL] [Abstract][Full Text] [Related]
17. Stealth effect of biomolecular corona on nanoparticle uptake by immune cells. Caracciolo G; Palchetti S; Colapicchioni V; Digiacomo L; Pozzi D; Capriotti AL; La Barbera G; Laganà A Langmuir; 2015 Oct; 31(39):10764-73. PubMed ID: 26378619 [TBL] [Abstract][Full Text] [Related]
18. Analysis of lipid adsorption on nanoparticles by nanoflow liquid chromatography-tandem mass spectrometry. Lee JY; Wang H; Pyrgiotakis G; DeLoid GM; Zhang Z; Beltran-Huarac J; Demokritou P; Zhong W Anal Bioanal Chem; 2018 Sep; 410(24):6155-6164. PubMed ID: 29845324 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous metabolomics and lipidomics analysis based on novel heart-cutting two-dimensional liquid chromatography-mass spectrometry. Wang S; Zhou L; Wang Z; Shi X; Xu G Anal Chim Acta; 2017 May; 966():34-40. PubMed ID: 28372724 [TBL] [Abstract][Full Text] [Related]